
This retrospective study evaluated the impact of repeated intravitreal injections (IVI) of an anti-vascular endothelial growth factor (anti-VEGF) agent on glaucomatous progression in eyes with glaucoma spectrum diseases (GSD). The analysis found that while retinal nerve fiber layer thickness decreased significantly in both injected and uninjected eyes, repeated IVI did not show a significant difference in glaucomatous progression. Factors like baseline retinal nerve fiber layer thickness were associated with greater absolute thickness loss. The study suggests that further investigations with extended follow-up are necessary to fully understand the long-term effects of repeated IVI.
Like
Save
Share